Chronic Pancreatitis and Pancreatic Cancer

被引：28
|
作者：
Li, Bai-Rong [1 ]
Hu, Liang-Hao [1 ,2 ]
Li, Zhao-Shen [1 ,2 ]
机构：
[1] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai, Peoples R China
来源：
GASTROENTEROLOGY | 2014年 / 147卷 / 02期
关键词：
RISK;
D O I：
10.1053/j.gastro.2014.03.054
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：541 / 542
页数：3
相关论文
共 50 条
  • [1] Chronic Pancreatitis and Pancreatic Cancer
    Kong, Xiangyu
    Sun, Tao
    Kong, Fanyang
    Du, Yiqi
    Li, Zhaoshen
    GASTROINTESTINAL TUMORS, 2014, 1 (03) : 123 - 134
  • [2] Chronic pancreatitis and pancreatic cancer
    Gullo, L
    GASTROENTEROLOGY, 1996, 110 (03) : 968 - 969
  • [3] Pancreatic Cancer in Chronic Pancreatitis
    Dhar P.
    Kalghatgi S.
    Saraf V.
    Indian Journal of Surgical Oncology, 2015, 6 (1) : 57 - 62
  • [4] Chronic pancreatitis and pancreatic cancer
    Maisonneuve, P
    Lowenfels, AB
    DIGESTIVE DISEASES, 2002, 20 (01) : 32 - 37
  • [5] Pancreatic cancer or chronic pancreatitis?
    Berthelemy, P
    Pariente, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (02): : 149 - 151
  • [6] Chronic pancreatitis and pancreatic cancer
    不详
    GASTROENTEROLOGY, 1997, 113 (02) : 372 - 372
  • [7] Chronic Pancreatitis and Pancreatic Cancer Reply
    Bang, Ulrich Christian
    Benfield, Thomas
    Hyldstrup, Lars
    Bendtsen, Flemming
    Jensen, Jens-Erik Beck
    GASTROENTEROLOGY, 2014, 147 (02) : 542 - 542
  • [8] Development of pancreatic cancer in chronic pancreatitis
    Schlosser, W
    Schoenberg, MH
    Rhein, E
    Siech, M
    Gansauge, F
    Beger, HG
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (01): : 3 - 8
  • [9] Chronic pancreatitis and pancreatic cancer - Reply
    Bansal, P
    Sonnenberg, A
    GASTROENTEROLOGY, 1996, 110 (03) : 969 - 969
  • [10] Chronic Pancreatitis and the Development of Pancreatic Cancer
    Kandikattu, Hemanth K.
    Venkateshaiah, Sathisha U.
    Mishra, Anil
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (08) : 1182 - 1210
12345